135 related articles for article (PubMed ID: 24272591)
1. Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy.
Taguchi T; Nakayama S; Fujimoto S; Terada Y
Endocrine; 2014 Jun; 46(2):357-9. PubMed ID: 24272591
[No Abstract] [Full Text] [Related]
2. Propylthiouracil and antineutrophil cytoplasmic antibody associated vasculitis: the detective finds a clue.
Pillinger MH; Staud R
Semin Arthritis Rheum; 2006 Aug; 36(1):1-3. PubMed ID: 16887462
[No Abstract] [Full Text] [Related]
3. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
4. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.
Ohtsuka M; Yamashita Y; Doi M; Hasegawa S
Eur Respir J; 1997 Jun; 10(6):1405-7. PubMed ID: 9192950
[TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy.
Otsuka S; Kinebuchi A; Tabata H; Yamakage A; Yamazaki S
Br J Dermatol; 2000 Apr; 142(4):828-30. PubMed ID: 10792251
[No Abstract] [Full Text] [Related]
8. Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: successful management with oral corticosteroids.
Matsubara K; Nigami H; Harigaya H; Osaki M; Baba K
Pediatr Int; 2000 Apr; 42(2):170-3. PubMed ID: 10804735
[No Abstract] [Full Text] [Related]
9. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
10. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Takayasu's arteritis and antineutrophil cytoplasmic antibody-related glomerulonephritis related to use of propylthiouracil.
Baker-LePain JC; Farmer-Boatwright MK; Dooley MA
J Rheumatol; 2009 Jul; 36(7):1552-4. PubMed ID: 19567638
[No Abstract] [Full Text] [Related]
12. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.
Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A
Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
[TBL] [Abstract][Full Text] [Related]
14. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody.
Hong SB; Lee MH
Dermatology; 2004; 208(4):339-41. PubMed ID: 15178918
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
16. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil-induced diffuse proliferative lupus nephritis: review of immunological complications.
Prasad GV; Bastacky S; Johnson JP
J Am Soc Nephrol; 1997 Jul; 8(7):1205-10. PubMed ID: 9219172
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).
Nakamori Y; Tominaga T; Inoue Y; Shinohara K
Intern Med; 2003 Jun; 42(6):529-33. PubMed ID: 12857055
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy.
Erten Y; Bodur H; Sahiner S; Tolunay O; Akkaya V; Canbakan B; Bali M
Clin Endocrinol (Oxf); 2002 Nov; 57(5):699-700. PubMed ID: 12390348
[No Abstract] [Full Text] [Related]
[Next] [New Search]